Imunon/$IMNN
1D1W1MYTD1Y5YMAX
Capital at risk
About Imunon
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
- Ticker
- $IMNN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 20
- Headquarters
- Lawrenceville, United States
- Website
- imunon.com
Imunon Metrics
BasicAdvanced
$7.6M
-
-$3.57
1.98
-
Price and volume
Market cap
$7.6M
Beta
1.98
52-week high
$5.64
52-week low
$1.33
Average daily volume
92K
Financial strength
Current ratio
1.819
Quick ratio
1.436
Long term debt to equity
1.412
Total debt to equity
1.873
Interest coverage (TTM)
-191.99%
Profitability
EBITDA (TTM)
-14.546
Management effectiveness
Return on assets (TTM)
-77.99%
Return on equity (TTM)
-429.72%
Valuation
Price to book
3.28
Price to tangible book (TTM)
3.28
Price to free cash flow (TTM)
-0.37
Free cash flow yield (TTM)
-270.39%
Free cash flow per share (TTM)
-3.677
Growth
Earnings per share change (TTM)
-70.51%
3-year earnings per share growth (CAGR)
-57.92%
Upcoming events
No upcoming events
Imunon News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.